NYSE:PFE - Pfizer Stock Price, Forecast & News

Pfizer trades on the New York Stock Exchange (NYSE) under the ticker symbol "PFE."

Pfizer declared a quarterly dividend on Monday, December 16th. Stockholders of record on Friday, January 31st will be given a dividend of $0.38 per share on Friday, March 6th. This represents a $1.52 dividend on an annualized basis and a dividend yield of 4.38%. The ex-dividend date is Thursday, January 30th. This is an increase from Pfizer's previous quarterly dividend of $0.36. View Pfizer's Dividend History.

Pfizer declared that its Board of Directors has approved a share repurchase program on Friday, December 14th 2018, which authorizes the company to buyback $10,000,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to repurchase up to 3.8% of its stock through open market purchases. Stock buyback programs are usually a sign that the company's board of directors believes its stock is undervalued.

Pfizer Inc. (NYSE:PFE) announced its quarterly earnings results on Tuesday, January, 28th. The biopharmaceutical company reported $0.55 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.57 by $0.02. The biopharmaceutical company earned $12.69 billion during the quarter, compared to analysts' expectations of $12.73 billion. Pfizer had a net margin of 31.44% and a return on equity of 27.23%. Pfizer's revenue was down 9.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.64 earnings per share. View Pfizer's Earnings History.

Pfizer is scheduled to release their next quarterly earnings announcement on Tuesday, May 5th 2020. View Earnings Estimates for Pfizer.

Pfizer issued an update on its FY20 earnings guidance on Tuesday, January, 28th. The company provided earnings per share (EPS) guidance of $2.82-$2.92 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.72. The company issued revenue guidance of $48.5-$50.5 billion, compared to the consensus revenue estimate of $47.44 billion.

11 brokers have issued 1-year price targets for Pfizer's shares. Their forecasts range from $36.00 to $53.00. On average, they anticipate Pfizer's stock price to reach $42.12 in the next year. This suggests a possible upside of 21.5% from the stock's current price. View Analyst Price Targets for Pfizer.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pfizer in the last year. There are currently 7 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Pfizer.

Media headlines about PFE stock have been trending neutral this week, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Pfizer earned a coverage optimism score of 0.4 on InfoTrie's scale. They also assigned media stories about the biopharmaceutical company a news buzz of 9.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for Pfizer.

Some companies that are related to Pfizer include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), AbbVie (ABBV), Eli Lilly And Co (LLY), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Allergan (AGN), Mylan (MYL), Perrigo (PRGO), Jazz Pharmaceuticals (JAZZ), The Medicines (MDCO), Horizon Therapeutics (HZNP), Nektar Therapeutics (NKTR), Pacira Biosciences (PCRX) and Corcept Therapeutics (CORT).

Based on aggregate information from My MarketBeat watchlists, some companies that other Pfizer investors own include AT&T (T), Cisco Systems (CSCO), Verizon Communications (VZ), Johnson & Johnson (JNJ), Intel (INTC), General Electric (GE), AbbVie (ABBV), Exxon Mobil (XOM), Bank of America (BAC) and Walt Disney (DIS).

Pfizer's stock is owned by a variety of of retail and institutional investors. Top institutional investors include State Street Corp (5.27%), Capital World Investors (3.41%), Geode Capital Management LLC (1.61%), Bank of New York Mellon Corp (1.08%), Massachusetts Financial Services Co. MA (0.94%) and Charles Schwab Investment Management Inc. (0.72%). Company insiders that own Pfizer stock include Alexander R Mackenzie, Charles H Hill, Dawn Rogers, Douglas M Lankler, Frank A Damelio, Ian C Read, Kirsten Lund-Jurgensen, Laurie J Olson, Loretta V Cangialosi, Mikael Dolsten, Pfizer Inc, Rady A Johnson, Sally Susman, Scott Gottlieb and W Don Cornwell. View Institutional Ownership Trends for Pfizer.

PFE stock was sold by a variety of institutional investors in the last quarter, including Capital International Investors, Massachusetts Financial Services Co. MA, PGGM Investments, California Public Employees Retirement System, LSV Asset Management, CI Investments Inc., PNC Financial Services Group Inc. and KBC Group NV. Company insiders that have sold Pfizer company stock in the last year include Alexander R Mackenzie, Dawn Rogers, Frank A Damelio, Mikael Dolsten and Rady A Johnson. View Insider Buying and Selling for Pfizer.

PFE stock was purchased by a variety of institutional investors in the last quarter, including Capital World Investors, Renaissance Technologies LLC, Marshall Wace North America L.P., Sanders Capital LLC, Bank of New York Mellon Corp, FIL Ltd, Sound Shore Management Inc. CT and Marshall Wace LLP. Company insiders that have bought Pfizer stock in the last two years include Pfizer Inc and Scott Gottlieb. View Insider Buying and Selling for Pfizer.

Shares of PFE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of PFE stock can currently be purchased for approximately $34.67.

Pfizer has a market capitalization of $191.87 billion and generates $51.75 billion in revenue each year. The biopharmaceutical company earns $16.27 billion in net income (profit) each year or $2.95 on an earnings per share basis. Pfizer employs 92,400 workers across the globe.View Additional Information About Pfizer.

The official website for Pfizer is http://www.pfizer.com/.

Pfizer's mailing address is 235 EAST 42ND STREET, NEW YORK NY, 10017. The biopharmaceutical company can be reached via phone at 212-733-2323.